About Kenvue Inc.
Kenvue, spun off from Johnson & Johnson in 2023, sells Tylenol, Listerine, Band-Aid, Neutrogena, and Aveeno. Steady consumer health demand, though private-label competition and input costs pressure margins. Low volatility, pays a dividend. Defensive staples name generating modest CSP premiums for conservative sellers.
Consumer Health Products